Nucleic acid amplification technologies.

R D Abramson; T W Myers

doi:10.1016/0958-1669(93)90030-z

Home/Archive/PubMed

PubMed · 7763392

Nucleic acid amplification technologies.

R D Abramson·T W Myers

View original source ↗Export metadata ↓

Abstract

The polymerase chain reaction, Q beta replicase methodology, the ligase chain reaction, the self-sustained sequence replication system, and the new strand displacement assay have continued to progress with the development of improved reagents and new applications. These advances in enzymatic nucleic acid amplification strategies continue to provide research and medical communities with an ever-improving arsenal of ways to amplify RNA and DNA.

Explore related subjects

Gene Amplification Humans Ligases Nucleic Acids Polymerase Chain Reaction Q beta Replicase Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

R D Abramson, T W Myers. 1993. Nucleic acid amplification technologies.. https://doi.org/10.1016/0958-1669(93)90030-z

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1999

Wild-type sequence of MYCN in neuroblastoma cell lines.

Explore the source record for details and available documents.

Gene Amplification↗

PubMed1998

[Diagnosis of infections with difficulty in isolation and identification of the causative organisms. 3) Acid-fast bacterial infections (caused by Mycobacterium tuberculosis or atypical acid-fast organisms)].

Explore the source record for details and available documents.

Gene Amplification↗

PubMed1998

Preliminary experience in external quality control of RT-PCR PML-RAR alpha detection in promyelocytic leukemia.

To standardize the results obtained in PML/RAR alpha RT-PCR detection by laboratories of hospitals involved in the Spanish Program for Treatment of Hematological Malignancies (PETHEMA) LPA-96, designed for the treatment of acute promyelocytic leukemia (APL), cDNA samples obtained by reverse transcription of RNA from bone marrow samples of patients with APL were sent to participating laboratories. During the first year of this external quality assessment trial nine samples were tested by a maximum of 12 laboratories. The control gene was satisfactorily amplified in 90% of the samples (62 of 69 samples), supporting the adequacy of the cDNA to be used as control sample. There was an 83% concordance between laboratories for PML/RAR alpha detection with similar results for the type of PML/RR alpha rearrangements. However, 17% disagreement still remained, attributable to low sensitivity or inadequacy of methods followed. The results stressed the need for implementation of an external quality assessment scheme to ensure the standardization of the results.

Gene Amplification↗